持续血糖监测设备市场规模、份额及成长分析（按组件、连接性、性别、最终用途和地区）- 产业预测 2025-2032

持续血糖监测设备市场规模预计在 2023 年达到 86.7 亿美元，并从 2024 年的 98.4 亿美元增长到 2032 年的 271 亿美元，预测期内（2025-2032 年）的复合年增长率为 13.5%。

由于糖尿病盛行率不断上升以及连续血糖监测 (CGM) 设备的普及，糖尿病市场正在经历显着增长。国际糖尿病联盟报告称，2022 年将有约 5.366 亿人被诊断患有糖尿病，并预测到 2030 年这一数字将上升到 6.428 亿，到 2045 年将上升到 7.837 亿。 CGM 设备不仅提供有关饮食行为、药物依从性和身体活动的关键资料，而且还透过先进的数位治疗解决方案改善製造商与患者的关係。许多应用程式正在整合 CGM资料来分析趋势并建议改变生活方式以改善患者的整体治疗效果，从而支持 CGM 设备市场的成长轨迹。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 宏观经济指标
• 价值链分析
• 定价分析
• 案例研究
• 技术进步
• 监管格局
• 客户和购买标准分析
• 专利分析

持续血糖监测设备市场规模（按组件划分）

• 市场概况
• 发送器
• 感应器
• 接收器

持续血糖监测设备市场规模（依连接类型）

• 市场概况
• Bluetooth
• 4G
• 其他的

持续血糖监测设备市场规模（依最终用途划分）

• 市场概况
• 医院
• 居家护理

持续血糖监测设备市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Abbott Laboratories（USA）
• Dexcom, Inc.（USA）
• Medtronic PLC（Ireland）
• Roche（Switzerland）
• Senseonics Holdings, Inc.（USA）
• GlySens Incorporated（USA）
• Novo Nordisk A/S（Denmark）
• Insulet Corporation（USA）
• Tandem Diabetes Care, Inc.（USA）
• Ascensia Diabetes Care Holdings AG（Switzerland）
• Ypsomed AG（Switzerland）
• Menarini Diagnostics（Italy）
• Nemaura Medical Inc.（UK）
• Medisana GmbH（Germany）
• Sanofi（France）
• Johnson & Johnson（USA）
• Braun Melsungen AG（Germany）
• Arkray, Inc.（Japan）
• Terumo Corporation（Japan）
• MicroTech Medical（China）

结论和建议

Continuous Glucose Monitoring Devices Market size was valued at USD 8.67 billion in 2023 and is poised to grow from USD 9.84 billion in 2024 to USD 27.1 billion by 2032, growing at a CAGR of 13.5% during the forecast period (2025-2032).

The diabetes market is witnessing significant growth driven by the rising prevalence of the condition and the increasing adoption of continuous glucose monitoring (CGM) devices. The International Diabetes Federation reported that around 536.6 million people were diagnosed with diabetes in 2022, with estimates predicting this figure will rise to 642.8 million by 2030 and 783.7 million by 2045. CGM devices not only provide critical data on dietary behaviors, medication adherence, and physical activity but also foster improved relationships between manufacturers and patients through advanced digital therapeutic solutions. Numerous applications integrate CGM data to analyze trends and recommend lifestyle changes, collectively enhancing patient outcomes and propelling the growth trajectory of the CGM device market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Continuous Glucose Monitoring Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Continuous Glucose Monitoring Devices Market Segments Analysis

Global Continuous Glucose Monitoring Devices Market is segmented by Component, Connectivity, End-use and region. Based on Component, the market is segmented into Transmitters, Sensors and Receivers. Based on Connectivity, the market is segmented into Bluetooth, 4G and Others. Based on End-use, the market is segmented into Hospitals and Homecare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Continuous Glucose Monitoring Devices Market

The rising incidence of diabetes worldwide serves as a crucial catalyst for the growth of the Continuous Glucose Monitoring (CGM) Devices market. As the number of individuals managing diabetes continues to climb, there is an urgent need for reliable monitoring and management technologies. Continuous glucose monitoring devices provide real-time feedback, enabling better control of blood sugar levels and improving overall health outcomes for patients. This demand drives innovation and investment in CGM technology, fostering advancements that enhance user experience and accuracy. Consequently, the market for these devices is positioned for substantial growth, addressing the critical needs of an expanding population affected by diabetes.

Restraints in the Continuous Glucose Monitoring Devices Market

Despite advancements in the accuracy of continuous glucose monitoring devices, they can occasionally display discrepancies when compared to traditional blood glucose testing methods. This inconsistency raises concerns among users who rely on precise measurements for managing their health. Such reliability issues can lead to diminished trust in the devices, prompting some individuals to prefer conventional testing approaches. As a result, the perceived accuracy challenges of these innovative tools may become a significant restraint within the market, potentially affecting adoption rates and user satisfaction. Addressing these discrepancies is essential for manufacturers to enhance user confidence and expand market reach.

Market Trends of the Continuous Glucose Monitoring Devices Market

The Continuous Glucose Monitoring (CGM) Devices market is witnessing a significant trend towards integration with digital health platforms, enhancing user experience and data management. This integration allows individuals with diabetes to effortlessly monitor their glucose levels alongside other vital health metrics, facilitating a comprehensive approach to health management. Through mobile applications and cloud-based systems, users can access real-time data, receive personalized insights, and share information with healthcare providers, improving communication and care outcomes. As consumers increasingly seek connected health solutions, this trend is likely to drive growth in the CGM market, fostering innovation and expanding the overall digital health ecosystem.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Advancement
• Regulatory Landscape
• Customer & Buying Criteria Analysis
• Patent Analysis

Global Continuous Glucose Monitoring Devices Market Size by Component & CAGR (2025-2032)

• Market Overview
• Transmitters
• Sensors
• Receivers

Global Continuous Glucose Monitoring Devices Market Size by Connectivity & CAGR (2025-2032)

• Market Overview
• Bluetooth
• 4G
• Others

Global Continuous Glucose Monitoring Devices Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Homecare

Global Continuous Glucose Monitoring Devices Market Size & CAGR (2025-2032)

• North America (Component, Connectivity, End-use)
  • US
  • Canada
• Europe (Component, Connectivity, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Component, Connectivity, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Component, Connectivity, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Component, Connectivity, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Senseonics Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlySens Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ascensia Diabetes Care Holdings AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Menarini Diagnostics (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nemaura Medical Inc. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medisana GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arkray, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroTech Medical (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations